| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25 | 17 | 29 | 25 | | Cost of Revenue | 146 | 152 | 121 | 155 | | | Gross Profit | (121) | (135) | (92) | (130) | | | Operating Expenses | | Research Development | 1,173 | 1,982 | 1,595 | 1,739 | | Selling General and Administrative | 1,164 | 1,862 | 1,166 | 1,116 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,458) | (3,979) | (2,853) | (2,985) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23 | 109 | (234) | 148 | | Earnings Before Interest And Taxes | (2,435) | (3,870) | (3,087) | (2,837) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,435) | (3,870) | (3,087) | (2,837) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,435) | (3,870) | (3,087) | (2,837) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,435) | (3,870) | (3,087) | (2,837) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,435) | ($3,870) | ($3,087) | ($2,837) |
|
0.50% Nasdaq 0.00%
Income Statement
